Received: from AM4PEPF00027A65.eurprd04.prod.outlook.com (2603:10a6:400:1d6:cafe::be) by CWLP265CA0387.outlook.office365.com (2603:10a6:400:1d6::8) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.71.13 via Frontend Transport; Wed, 27 May 2026 07:46:42 +0000 Received: from CWLP265CA0387.GBRP265.PROD.OUTLOOK.COM (2603:10a6:400:1d6::8) by GVUPR02MB11975.eurprd02.prod.outlook.com (2603:10a6:150:35a::21) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.25.24; Wed, 27 May 2026 07:46:42 +0000 Received: from westeu12-emailsignatures-cloud.codetwo.com (13.93.42.39) by AM4PEPF00027A65.mail.protection.outlook.com (10.167.16.86) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.71.7 via Frontend Transport; Wed, 27 May 2026 07:46:41 +0000 Received: from AS8PR07CU003.outbound.protection.outlook.com (40.93.65.52) by westeu12-emailsignatures-cloud.codetwo.com with CodeTwo SMTP Server (TLS12) via SMTP; Wed, 27 May 2026 07:46:41 +0000 Received: from GV2PR02MB11921.eurprd02.prod.outlook.com ([fe80::9f24:8c81:10e8:7104]) by GV2PR02MB11921.eurprd02.prod.outlook.com ([fe80::9f24:8c81:10e8:7104%4]) with mapi id 15.21.0071.010; Wed, 27 May 2026 07:46:39 +0000 Received: from GV2PR02MB11921.eurprd02.prod.outlook.com (2603:10a6:150:351::5) by AS5PR02MB11414.eurprd02.prod.outlook.com (2603:10a6:20b:6c4::11) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.71.12; Wed, 27 May 2026 07:46:39 +0000 Received: from GVUPR02MB11975.eurprd02.prod.outlook.com (2603:10a6:150:35a::21) by AM0PR02MB5011.eurprd02.prod.outlook.com with HTTPS; Wed, 27 May 2026 07:46:46 +0000 From: "Kommunikatsioon - RA" To: =?iso-8859-1?Q?K=E4rolin_Jenas_-_RA?= References: In-Reply-To: Subject: =?iso-8859-1?Q?Ed:_P=E4ring_Delfist?= Date: Wed, 27 May 2026 10:46:39 +0300 Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_035D_01DCEE7E.5C2D39B0" X-Mailer: Microsoft Outlook 16.0 Authentication-Results: spf=pass (sender IP is 13.93.42.39) smtp.mailfrom=ravimiamet.ee; dkim=none (message not signed) header.d=none;dmarc=pass action=none header.from=ravimiamet.ee; Received-SPF: Pass (protection.outlook.com: domain of ravimiamet.ee designates 13.93.42.39 as permitted sender) receiver=protection.outlook.com; client-ip=13.93.42.39; helo=westeu12-emailsignatures-cloud.codetwo.com; pr=C Authentication-Results-Original: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; X-MS-Exchange-Organization-ExpirationStartTime: 27 May 2026 07:46:41.7493 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 29e52277-9a7f-45a1-5dcd-08debbc4179f X-EOPAttributedMessage: 0 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: GV2PR02MB11921:EE_|AS5PR02MB11414:EE_|AM4PEPF00027A65:EE_|GVUPR02MB11975:EE_|AM0PR02MB5011:EE_ X-MS-Exchange-Organization-AuthSource: GV2PR02MB11921.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Office365-Filtering-Correlation-Id: 29e52277-9a7f-45a1-5dcd-08debbc4179f X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|39142699007|31052699007|82310400026|366016|35042699022|56012099006|11063799006|22082099003|18002099003|55112099003|8096899003|41050700001; X-Forefront-Antispam-Report: CIP:13.93.42.39;CTRY:NL;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:westeu12-emailsignatures-cloud.codetwo.com;PTR:westeu12-emailsignatures-cloud.codetwo.com;CAT:NONE;SFS:(13230040)(39142699007)(31052699007)(82310400026)(366016)(35042699022)(56012099006)(11063799006)(22082099003)(18002099003)(55112099003)(8096899003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 27 May 2026 07:46:41.7450 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 29e52277-9a7f-45a1-5dcd-08debbc4179f X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: GV2PR02MB11921.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem X-MS-Exchange-Transport-CrossTenantHeadersStamped: AS5PR02MB11414 X-MS-Exchange-Transport-CrossTenantHeadersStamped: GVUPR02MB11975 X-MS-Exchange-Transport-EndToEndLatency: 00:00:04.5764184 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0071.000 X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: 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 Thread-Index: AQHhMqwsUcJdukcjUgMgvFtEL0sR+QEAisfc X-MS-Has-Attach: X-MS-TNEF-Correlator: X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|39142699007|31052699007|366016|55112099003|56012099006|11063799006|18002099003|22082099003|8096899003|41050700001; X-Microsoft-Antispam-Message-Info-Original: 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 X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:GV2PR02MB11921.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(39142699007)(31052699007)(366016)(55112099003)(56012099006)(11063799006)(18002099003)(22082099003)(8096899003)(41050700001);DIR:INT; X-Exchange-RoutingPolicyChecked: OrejqBMc4xgqW235nzQVt5cKpHn0Uc/06ULfG3O8kf48S6FfPesJc0/xQATXQpE32QRHh6oWu6KEEuzMmfZerKl3UOOyOdivVjDh5AoH+J6N6hqxEIY3+oeV+YwJqUlCxZP8kwd2a63vtlnURm05DvTqHNmIQtNmj3Io5uhjJn39LJdKg0RLRvjC7Xy+PV7ZMQU53fKzaI5gGy7uH8Ul4Rjvu6IKmzK/4rbSFxT7gMnvJOSsXGTLFYWg6v3vAzYpXZQ+axfVntjiHhBabnbc30/HA3fL/dwm5gi6i810cAAJj9dsCGjeuXvWyMS0qMPeGmnv6ysto6Re928wwc3dGQ== X-OrganizationHeadersPreserved: AS5PR02MB11414.eurprd02.prod.outlook.com X-CodeTwo-MessageID: 37ec150b-c1be-49f2-ad57-3991556e4598.20260527074641@westeu12-emailsignatures-cloud.codetwo.com X-CodeTwoProcessed: true X-MS-Exchange-Organization-AuthMechanism: 04 X-CrossPremisesHeadersPromoted: AM4PEPF00027A65.eurprd04.prod.outlook.com X-CrossPremisesHeadersFiltered: AM4PEPF00027A65.eurprd04.prod.outlook.com X-MS-Exchange-Transport-CrossTenantHeadersStripped: AM4PEPF00027A65.eurprd04.prod.outlook.com X-OriginatorOrg: m1wmgpm3xrpm87txzdfw82by7.smtp.codetwo.online X-MS-Office365-Filtering-Correlation-Id-Prvs: f9545f80-f36a-4ccf-3fa7-08debbc4166a X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;Ip=[13.93.42.39];Helo=[westeu12-emailsignatures-cloud.codetwo.com] X-MS-Exchange-ExternalInOutlookResult: NotEnabled Content-Language: et x-ms-exchange-organization-originalclientipaddress: 45.156.32.33 x-ms-exchange-organization-originalserveripaddress: 10.167.16.86 acceptlanguage: en-US msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-05-27T07:46:39.047Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; X-OlkEid: 000000004C30E2D3CD34B4428531CBEB8A7CAB89070034AD76187591974DBF6C4F76951C873A0100020000000000B04CDEF8D3227A448511457FBBCE9C870000000009B800009E42ADC59BE47D4CAE33296FE4BF7EAF This is a multipart message in MIME format. ------=_NextPart_000_035D_01DCEE7E.5C2D39B0 Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-Encoding: 8bit _____ Saatja: Eliisabet Voomets Saadetud: esmaspäev, 25. mai 2026 21:54 Adressaat: Kommunikatsioon - RA Teema: Päring Delfist Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tere! Kirjutan Teile Delfist. Olen tegemas lugu iluteenustest ja -protseduuridest ning Terviseametiga vesteldes ütlesid nad, et võiksin selle teemaga Teie poole pöörduda. Nimelt on Eestis väidetavalt tõusmas probleem, kus inimesed soovivad lasta omale süstida aineid, mida ei ole tegelikult uuritud ja neid tuuakse illegaalselt riiki. Uurin, kas Ravimiamet on teemaga kokku puutunud? Oskate selle kohta midagi rääkida? Aitäh! Parimat Eliisabet Voomets Delfi ajakirjanik 56685210 ------=_NextPart_000_035D_01DCEE7E.5C2D39B0 Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable

Saatja: Eliisabet = Voomets <eliisabet.voomets@delfi.ee>
Saadetud: esmasp=E4ev, 25. mai 2026 21:54
Adressaat: Kommunikatsioon - RA <press@ravimiamet.ee>
Teema: P=E4ring Delfist
 

T=E4helepanu! Tegemist on v=E4lisv=F5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.
Tere!

Kirjutan Teile Delfist. Olen tegemas lugu iluteenustest ja = -protseduuridest ning Terviseametiga vesteldes =FCtlesid nad, et = v=F5iksin selle teemaga Teie poole p=F6=F6rduda.

Nimelt on Eestis v=E4idetavalt t=F5usmas probleem, kus inimesed soovivad = lasta omale s=FCstida aineid, mida ei ole tegelikult uuritud ja neid = tuuakse illegaalselt riiki. Uurin, kas Ravimiamet on teemaga kokku = puutunud? Oskate selle kohta midagi r=E4=E4kida?

Ait=E4h!

Parimat
Eliisabet Voomets
Delfi ajakirjanik
56685210
------=_NextPart_000_035D_01DCEE7E.5C2D39B0--